These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24908142)

  • 1. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
    Landau MS; Kuan SF; Chiosea S; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Metastasis of Transverse Colon Cancer with an Aberrant Pattern of CK7/CK20/CDX2 and High Microsatellite Instability.
    Omiya M; Murata T; Sawaki A; Teshima S; Kawachi J
    Intern Med; 2023 Dec; 62(24):3625-3630. PubMed ID: 37164671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of the colon cancer in South-Eastern Romania: Results from the MERCUR study.
    Popescu RC; Tocia C; Brînzan C; Cozaru GC; Deacu M; Dumitru A; Leopa N; Mitroi AF; Nicolau A; Dumitru E
    Medicine (Baltimore); 2021 Jan; 100(1):e24062. PubMed ID: 33429770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer.
    Lee KS; Kwak Y; Ahn S; Shin E; Oh HK; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    Cancer Immunol Immunother; 2017 Jul; 66(7):927-939. PubMed ID: 28405764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers.
    Lee JA; Park HE; Jin HY; Jin L; Cho NY; Bae JM; Kim JH; Kang GH
    Ann Diagn Pathol; 2024 Aug; 71():152289. PubMed ID: 38555678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining.
    Kwon CH; Ahn JH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Park YM; Noh BG
    World J Surg Oncol; 2024 Jan; 22(1):5. PubMed ID: 38167037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
    Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in Colorectal Adenocarcinoma.
    Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
    Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas.
    Katkoori VR; Shanmugam C; Jia X; Vitta SP; Sthanam M; Callens T; Messiaen L; Chen D; Zhang B; Bumpers HL; Samuel T; Manne U
    PLoS One; 2012; 7(1):e30020. PubMed ID: 22276141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Microsatellite Instability and Gene Expression Profile in Colorectal Carcinoma and Potential Implications for Therapy.
    Kibriya MG; Jasmine F; Khamkevych Y; Raza M; Kamal M; Bissonnette M; Ahsan H
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541076
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer.
    Maitra R; Thavornwatanayong T; Venkatesh MK; Chandy C; Vachss D; Augustine T; Guzik H; Koba W; Liu Q; Goel S
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Chemotherapy for Microsatellite Instable-High Metastatic Colorectal Cancers.
    Shulman K; Barnett-Griness O; Friedman V; Greenson JK; Gruber SB; Lejbkowicz F; Rennert G
    JCO Precis Oncol; 2018; 2():. PubMed ID: 32913995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and evaluation of microsatellite stability of colorectal carcinoma with cribriform comedo pattern.
    Günler T; Karabağli P; Tiyek H; Keskin Ö; Körez MK
    Indian J Pathol Microbiol; 2024 Apr; 67(2):275-281. PubMed ID: 38394410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma.
    Otto W; Macrae F; Sierdziński J; Smaga J; Król M; Wilińska E; Zieniewicz K
    Medicine (Baltimore); 2019 Jan; 98(1):e13956. PubMed ID: 30608431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between microsatellite instability in colorectal adenocarcinoma and tumor budding and histopathological parameters.
    Topal U; Gülcan P; Yüksel S; Teke Z; Bektaş H; Duman M
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9793-9800. PubMed ID: 37916344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon Gamma Induces Higher Neutrophil Extracellular Traps Leading to Tumor-Killing Activity in Microsatellite Stable Colorectal Cancer.
    Teng HW; Wang TY; Lin CC; Tong ZJ; Cheng HW; Wang HT
    Mol Cancer Ther; 2024 Jul; 23(7):1043-1056. PubMed ID: 38346939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary cutaneous metastasis of colon cancer with microsatellite instability-high and BRAF V600E mutation treated with curative-intent surgery: a case report.
    Yamai D; Shimada Y; Ozeki H; Matsumoto A; Abe K; Tajima Y; Nakano M; Ichikawa H; Sakata J; Wakai T
    Surg Case Rep; 2023 Nov; 9(1):196. PubMed ID: 37962682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
    Roviello G; D'Angelo A; Petrioli R; Roviello F; Cianchi F; Nobili S; Mini E; Lavacchi D
    Transl Oncol; 2020 Sep; 13(9):100795. PubMed ID: 32470910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice.
    Badia-Ramentol J; Gimeno-Valiente F; Duréndez E; Martínez-Ciarpaglini C; Linares J; Iglesias M; Cervantes A; Calon A; Tarazona N
    Cancer Treat Rev; 2023 Dec; 121():102643. PubMed ID: 37871463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP1 expression in colon cancer predicts clinical outcome.
    Boulagnon-Rombi C; Schneider C; Leandri C; Jeanne A; Grybek V; Bressenot AM; Barbe C; Marquet B; Nasri S; Coquelet C; Fichel C; Bouland N; Bonnomet A; Kianmanesh R; Lebre AS; Bouché O; Diebold MD; Bellon G; Dedieu S
    Oncotarget; 2018 Feb; 9(10):8849-8869. PubMed ID: 29507659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.